Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
All >

News > Southern Europe & Israel

Please find below news about Albania, Bosnia and Herzegovina, Croatia, Greece, Israel, Italy, Malta, Montenegro, Portugal, Macedonia, Serbia, Slovenia, Spain and Turkey as well as about organisations from these countries.

Total search results: 419 | Ordered by Source (descending)
next pagenext page 1 2 3 4 5  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Oryzon Genomics S.A.. (10/3/17). "Press Release: Significant Fact [Company Moves Registered Address from Barcelona to Madrid]". Madrid. 2017-10-03
Oryzon Genomics S.A.. (10/26/18). "Press Release: Oryzon Raises EUR 13 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA or any other jurisdiction where unlawful]". Madrid & Cambridge, MA. 2018-10-26
Orgenesis Inc.. (11/29/21). "Press Release: Orgenesis and Theracell Joint Venture to Receive up to €32 Million From Greek Government to Accelerate Rollout of POCare Centers and Deployment of OMPULs". Germantown, MD. 2021-11-29
Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London. 2019-03-27
Optimapharm d.d.. (7/21/20). "Press Release: Optimapharm Appoints Dr. Andrew Copestake as Chief Executive Officer". 2020-07-21
Optimapharm d.d.. (2/6/19). "Press Release: Optimapharm Acquires Swiss Denothex and Becomes a Leading European Mid-size Clinical Research Organization". 2019-02-06
Oniria Therapeutics, S.L.. (5/11/23). "Press Release: Oniria Therapeutics Closes €1.28 Million Seed Funding Round". Barcelona. 2023-05-11
Oncgnostics GmbH. (4/16/18). "Press Release: Test for Uterine Cancer in Portugal. Biotech Firm Oncgnostics Grants Exclusive Licence for Cancer Screening Test". Lisbon & Jena. 2018-04-16
Ona Therapeutics. (6/16/20). "Press Release: Ona Therapeutics Raises €30m in Series A Financing". Barcelona. 2020-06-16
Ona Therapeutics. (12/2/21). "Press Release: Ona Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors". Barcelona. 2021-12-02
Nuage Therapeutics. (6/20/23). "Press Release: Nuage Therapeutics Raises €12M in Seed Financing Led by Sofinnova Partners and Asabys". Barcelona. 2023-06-20
Nuage Therapeutics. (5/10/22). "Press Release: Nuage Therapeutics Appoints Biotech Entrepreneur and Executive Judit Anido as CEO". Barcelona. 2022-05-10
Novartis AG. (7/20/23). "Press Release: Sandoz Announces Plans to Build a Biosimilar Technical Development Center in Slovenia to Support Future Growth of Biosimilar Pipeline". Basel. 2023-07-20
Novartis AG. (10/21/21). "Press Release: Novartis Signs New Initial Agreement with BioNTech to Support Fill and Finish of the mRNA Pfizer-BioNTech COVID-19 vaccine". Basel. 2021-10-21
NorthSea Therapeutics B.V.. (12/17/21). "Press Release: NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders". Amsterdam. 2021-12-17
Nordic Nanovector ASA. (6/25/18). "Press Release: Nordic Nanovector Appoints Eduardo Bravo as Chief Executive Officer". Oslo. 2018-06-25
NMS Group S.p.A.. (8/3/22). "Press Release: NMS Group S.p.A. Appoints Andrew Curtis as Chief Strategy Officer, Effective Immediately". 2022-08-03
NMS Group S.p.A.. (8/1/22). "Press Release: Nerviano Medical Sciences S.r.l. Expands US Presence". 2022-08-01
Newron Pharmaceuticals S.p.A.. (9/20/19). "Press Release: Newron Pharmaceutical Commercialization Partner Meiji Seika together with Eisai Announce the Approval of Safinamide for Parkinson’s Disease in Japan". Milan. 2019-09-20
Newron Pharmaceuticals S.p.A.. (3/21/17). "Press Release: FDA Approves Xadago (safinamide) for Parkinson’s Disease (PD) Patients". Milan & Morristown, NJ. 2017-03-21
Newron Pharmaceuticals S.p.A.. (3/2/17). "Press Release: Newron Announces 2016 Financial Results and Provides Outlook for 2017". Milan. 2017-03-02
Newron Pharmaceuticals S.p.A.. (10/30/18). "Press Release: Investment Plan for Europe. EIB Backs Italian CNS Drug Developer Newron Pharmaceuticals with up to EUR 40m". Luxembourg & Milan. 2018-10-30
NewAmsterdam Pharma B.V.. (6/28/22). "Press Release: NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe". Naarden, Miami, FL & Florence. 2022-06-28
Nerre Therapeutics Ltd.. (7/7/21). "Press Release: Nerre Therapeutics Raises £20 Million in a Series B2 Financing Round". Stevenage. 2021-07-07
Neovacs S.A.. (3/30/17). "Press Release: Neovacs Provides Corporate Update and Reports Full Year 2016 Financial Results". Paris. 2017-03-30
Navigo Proteins GmbH. (9/6/23). "Press Release: Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin Ligand Discovery Using Cutting-edge AI and Molecular Modeling Techniques". Halle (Saale) & Barcelona. 2023-09-06
Mologen AG. (8/1/18). "Press Release: Dr Ignacio Faus Appointed as New CEO of Mologen AG". Berlin. 2018-08-01
MolMed S.p.A.. (9/11/18). "Press Release: MolMed Appoints Mr. Salvatore Calabrese Chief Financial Officer". Milan. 2018-09-11
MolMed S.p.A.. (7/13/18). "Press Release: MolMed Signs a New, Three-year Agreement for the Development and Supply of Lentiviral Vectors. MolMed Will Provide GSK with Vectors for the Oncology Field". Milan. 2018-07-13
MolMed S.p.A.. (4/14/20). "Press Release: MolMed: the Board of Directors, Based on the Scientific Evidence from the Experiments on Early-stage Pre-clinical Products, Decided to Suspend the Investments in These Projects". Milan. 2020-04-14
MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan. 2020-03-09
MolMed S.p.A.. (3/7/19). "Press Release: MolMed and Genenta Science Confirm and Extend Their Partnership in the Oncology field". Milan. 2019-03-07
MolMed S.p.A.. (3/6/20). "Press Release: MolMed Signs a Multi-year Agreement and Announces the Beginning of a New Collaboration in the Field of T Cell Therapies". Milan. 2020-03-06
MolMed S.p.A.. (3/13/19). "Press Release: Partnership in the Field of Rare Genetic Diseases with Rocket Pharma Extended to Three New Therapeutic Indications". Milan. 2019-03-13
MolMed S.p.A.. (2/7/17). "Press Release: MolMed and TTY Biopharm Entered into a Term Sheet to Commercialise Zalmoxis in certain Asian Territories". Milan. 2017-02-07
MolMed S.p.A.. (2/27/17). "Press Release: MolMed and Rocket Pharma Establish a Collaboration Agreement in the Field of Gene Therapy for the Treatment of Fanconi Anemia". Milan. 2017-02-27
MolMed S.p.A.. (12/18/19). "Press Release: Italy – the EIB Supports MolMed Investment in Research, Development and Manufacturing for Cancer and Rare Diseases Innovative Treatments". Oxford. 2019-12-18
MolMed S.p.A.. (11/14/17). "Press Release: MolMed Completed the Fourth Tranche of the Share Capital Increase to Be Reserved to Société Générale Pursuant to “SEF – Standby Equity Facility” Agreement [Not for United States of America, Australia, Canada or 2017-11-14
MolMed S.p.A.. (10/10/19). "Press Release: MolMed Informs on Its Decision to Withdraw the Conditional Marketing Authorization of Zalmoxis". Milan. 2019-10-10
MolMed S.p.A. (at the request of AGC Inc.). (4/2/20). "Press Release: Offer Document Filed with Consob. Voluntary Public Tender Offer Launched by AGC Inc. on All the Ordinary Shares of MolMed S.p.A. [Not for release where violation of laws or regulations 2020-04-02
Moderna, Inc.. (7/9/20). "Press Release: Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate". Cambridge, MA & Madrid. 2020-07-09
Moderna, Inc.. (1/4/21). "Press Release: Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel". Cambridge, MA. 2021-01-04
Minoryx Therapeutics S.L.. (9/5/18). "Press Release: Minoryx Therapeutics Announces Dosing of First US Patient in Phase 2/3 Clinical study of MIN-102 (ADVANCE)". Mataró, Barcelona. 2018-09-05
Minoryx Therapeutics S.L.. (9/26/18). "Press Release: Minoryx Therapeutics Raises €21.3M in Series B Funding Round". Mataró, Barcelona. 2018-09-26
Minoryx Therapeutics S.L.. (9/21/18). "Press Release: A Consortium Led by Minoryx Receives €0.8m to Explore Additional Indications for MIN-102". 2018-09-21
Minoryx Therapeutics S.L.. (5/31/22). "Press Release: Minoryx Raises €51 Million to Support Marketing Authorization Application and Launch Preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy". Mataró, Barcelona. 2022-05-31
Minoryx Therapeutics S.L.. (3/12/19). "Press Release: Minoryx Therapeutics Appoints Didier Le Normand as Group Chief Financial Officer (CFO) and General Manager of Its Belgian Subsidiary". Mataró, Barcelona & Charleroi. 2019-03-12
Minoryx Therapeutics S.L.. (2/8/17). "Press Release: Dr Claude Nicaise Joins Minoryx Therapeutics as Independent Board Member". Mataró, Barcelona. 2017-02-08
Minoryx Therapeutics S.L.. (2/22/17). "Press Release: Minoryx Therapeutics Receives Orphan Drug Designation from the US FDA for Its Lead Candidate MIN-102". Mataró, Barcelona. 2017-02-22
Minoryx Therapeutics S.L.. (2/20/18). "Press Release: Minoryx Therapeutics Spins Off SEE-Tx Platform into New Company, Gain Therapeutics". Mataró, Barcelona & Lugano. 2018-02-20
Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. 2018-12-13
Minoryx Therapeutics S.L.. (1/26/21). "Press Release: Minoryx Presents Topline Results from Phase 2/3 »ADVANCE« Study Demonstrating Significant Clinical Benefit of Leriglitazone in Adrenomyeloneuropathy (AMN)". Mataró, Barcelona. 2021-01-26
Minoryx Therapeutics S.L.. (1/18/17). "Press Release: Minoryx Therapeutics Further Strengthens Its Scientific Advisory Board (SAB)". Mataró, Barcelona. 2017-01-18
Mind the Byte S.L.. (7/10/17). "Press Release: Mind the Byte Raises 300,000 Euros in Its Second Equity Crowdfunding". 2017-07-10
Mind the Byte S.L.. (5/9/17). "Press Release: Mind the Byte Launches a New Equity Crowdfunding Campaign with Crowdcube". 2017-05-09
Mind the Byte S.L.. (11/15/17). "Press Release: Mind the Byte and Prosilico Sign a Strategic Partnership Agreement". 2017-11-15
Mind the Byte S.L.. (1/11/18). "Press Release: Mind the Byte Acquires Intelligent Pharma". 2018-01-11
Mestrelab Research S.L.. (3/21/18). "Press Release: Mestrelab Research Response to ACDLabs Press Release about Lawsuit for Copyright Infringement". 2018-03-21
Merck KGaA. (9/21/22). "Press Release: Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor [ Not intended for US- or Canada- and UK-based media ]". Darmstadt. 2022-09-21
Merck KGaA. (9/1/17). "Press Release: Heinrich Emanuel Merck Award for Analytical Science Goes to Professor Francesco Ricci". Darmstadt. 2017-09-01
Merck KGaA. (8/31/17). "Press Release: Driving Innovation in Cancer Care at ESMO 2017 with New Data in Hard-to-Treat Cancers [Not intended for U.K. or U.S. based media]". Darmstadt. 2017-08-31
Merck KGaA. (8/23/17). "Press Release: Merck Sets Up PMatX Incubator in Israel for Next-Generation Electronics". Darmstadt. 2017-08-23
Merck KGaA. (7/8/21). "Press Release: Merck and Inbrain Neuroelectronics Collaborate to Develop the Next Generation of Bioelectronic Therapies". Darmstadt. 2021-07-08
Merck KGaA. (2/9/17). "Press Release: Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with Multiple Sclerosis". Darmstadt. 2017-02-09
Merck KGaA. (10/3/17). "Press Release: Merck Invests € 35 Million in Its Italian Biotech Manufacturing Site of Bari". Bari. 2017-10-03
MedLumics. (2/10/21). "Press Release: MedLumics Closes Upsized EUR 18M (21.7M USD) Financing Round and Appoints New Chairman". Madrid. 2021-02-10
Medivir AB. (3/16/17). "Press Release: Medivir Completes Transition of Commercial Products to Fully Focus on Research and Development". Stockholm. 2017-03-16
Medicen Paris Region. (5/23/17). "Press Release: French Tech Tour Healthcare Israel. Seven Start-ups Assess their Business Potential with Business France, Bpifrance and Medicen Paris Region". Paris. 2017-05-23
MagForce AG. (12/15/20). "Press Release: MagForce AG Successfully Completes Private Placement of New Shares". Berlin & Nevada. 2020-12-15
mAbxience S.L.. (2/13/17). "Press Release: mAbxience, European Success Accelerating Global Growth". 2017-02-13
Lunaphore Technologies S.A.. (9/9/18). "Press Release: Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat Frozen to Market". Lausanne & Florence. 2018-09-09
Lunaphore Technologies S.A.. (5/24/18). "Press Release: Lunaphore and Vitro Sign Collaboration Agreement to Develop ISH Protocols for RNA/DNA Targets". Lausanne & Seville. 2018-05-24
Lonza Group Ltd.. (9/8/20). "Press Release: Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy Manufactured Using the Lonza Cell Immunotherapy Manufactured Using the Lonza Cocoon Platform". Basel & Tel Aviv. 2020-09-08
Lonza Group AG. (5/16/17). "Press Release: Lonza Invests to Develop Exosomes for Next-generation Life Science Applications". Basel. 2017-05-16
Lonza Group AG. (11/19/18). "Press Release: Lonza Opens Collaborative Innovation Center in Haifa, Israel". Haifa. 2018-11-19
Lonza Group AG. (10/9/17). "Press Release: Lonza Announces Formation of New Research and Development Collaborative Innovation Center in Israel". Basel. 2017-10-09
LogicBio Therapeutics, Inc.. (6/27/17). "Press Release: LogicBio Therapeutics Announces $50 Million in Financing to Develop Novel Gene Medicines for Pediatric Patients". Cambridge, MA. 2017-06-27
Locust Walk Partners, LLC. (7/11/18). "Press Release: Locust Walk Appoints Lubor Gaal as Senior Vice President and Head of Europe to Further Advance Global Expansion of Transactions Business". London & Boston, MA. 2018-07-11
LNC Therapeutics. (4/15/20). "Press Release: LNC Therapeutics Announces the Acquisition of an Exclusive Worldwide Licence on the First Patent related to Christensenella’s Therapeutic Applications in Mood Disorders". Bordeaux. 2020-04-15
Lipopharma Therapeutics S.L.. (1/21/18). "Press Release: Lipopharma Awarded a 6.15m€ Grant by the H2020 Programme to Conduct a PIIb Trial with 2OHOA in Patients with Newly-diagnosed Glioblastoma". Palma de Mallorca & Acton, MA. 2018-01-21
Life Biosciences LLC. (1/9/19). "Press Release: Senolytic Therapeutics Kicks Off Q1 2019 with High-profile Speaking Events Featuring Co-founders Marc Ramis and Manuel Serrano". Boston, MA. 2019-01-09
LeanBio S.L.. (3/23/18). "Press Release: Syna Therapeutics, the New Joint Venture between LeanBio S.L. and Laboratoris Reig I Jofre". 2018-03-23
Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA. 2019-06-26
Laboratoris Sanifit S.L.. (3/6/18). "Press Release: Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis". Palma & San Diego, CA. 2018-03-06
Laboratoris Sanifit S.L.. (1/8/18). "Press Release: Sanifit Announces the Appointment of Cris Calsada as Chief Financial Officer". Palma & San Diego, CA. 2018-01-08
Kymos S.L.. (9/28/20). "Press Release: Kymos and Prolytic Merge to Become Kymos Group". Barcelona & Frankfurt a.M.. 2020-09-28
KWS Saat SE & Co. KGaA. (3/10/21). "Press Release: KWS Acquires Tomato Breeding Company". Einbeck & Wageningen. 2021-03-10
Kither Biotech S.r.l.. (7/5/19). "Press Release: Kither Biotech Raises a €5.6m Financing Round to Support the Clinical Development of a New Drug for Cystic Fibrosis and other Pulmonary Diseases". Turin. 2019-07-05
Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam. 2019-10-22
Keensight Capital. (7/23/19). "Press Release: Keensight Capital Acquires 3P Biopharmaceuticals to Accelerate Its Global Growth Strategy". Paris. 2019-07-23
Kaia Health Software GmbH. (11/30/20). "Press Release: Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets". Munich & Parma. 2020-11-30
Izana Bioscience Ltd.. (4/6/20). "Press Release: Initiation of Two-centre Compassionate Use Study Involving Namilumab in the Treatment of Individual Patients with Rapidly Worsening COVID-19 Infection in Italy". Oxford. 2020-04-06
Israel Advanced Technology Industries (IATI). (2/8/24). "Press Release: MIXiii Health-Tech.IL Annual Conference to Showcase Resilience and Growth of Israel's Life Sciences Industry Amid War". Herzliya. 2024-02-08
IRB Barcelona. (5/21/19). "Press Release: The IRB Barcelona Spin-off Ona Therapeutics Hits the Road Thanks to Sabadell Asabys". 2019-05-21
Iqvia. (4/30/18). "Press Release: Recordati Selects Iqvia’s OCE Technology Platform and OneKey Information Services". Danbury, CT & Research Triangle Park, NC. 2018-04-30
Ipsen S.A.. (1/31/17). "Press Release: Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma". Paris. 2017-01-31
Iproteos S.L.. (1/26/17). "Press Release: Grant of 700,000 € for the Discovery of Drugs against Atherosclerosis". 2017-01-26
Iontas Ltd.. (5/13/20). "Press Release: FairJourney Biologics Joins Forces with Iontas to Create a Global Leader in Outsourced Antibody Discovery Services". Porto & Cambridge. 2020-05-13
Ion Beam Applications S.A. (IBA). (12/8/22). "Press Release: IBA Wins 10 Proton Therapy System Contract in Spain". Louvain-la-Neuve. 2022-12-08
Invivo Partners. (3/5/24). "Press Release: Invivo Partners Is Preparing to Launch a €100M Invivo Ventures III Fund to Invest in Leading-edge Life Sciences". Barcelona. 2024-03-05
next pagenext page 1 2 3 4 5  next pagenext page



Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px

» top